ANIXA BIOSCIENCES INC (ANIX) vs Atara Biotherapeutics, Inc. (ATRA)

ANIXA BIOSCIENCES INC and Atara Biotherapeutics, Inc. are both Biotechnology companies. ANIXA BIOSCIENCES INC and Atara Biotherapeutics, Inc. are of similar size ($96.9M and $96.7M). ANIXA BIOSCIENCES INC grew revenue faster over the last twelve months: −34.1% against −96.7%. ANIXA BIOSCIENCES INC has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, ANIXA BIOSCIENCES INC leads on 7 and Atara Biotherapeutics, Inc. on 7.

Valuation

Metric ANIX ATRA Biotechnology median
P/E n/m n/m 8.50
P/S 93.90 22.28 9.71
P/B 6.91 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 83.50 20.69 9.21
Earnings yield (11.99%) (12.85%) (33.15%)
Free cash flow yield (8.04%) (15.24%) (25.50%)

Profitability

Metric ANIX ATRA Biotechnology median
Gross margin 0.00% 91.38% 65.16%
Operating margin 0.00% (229.67%) 0.00%
Net margin 0.00% (269.42%) 0.00%
Free cash flow margin 0.00% (353.49%) 0.00%
Return on equity (72.57%) 46.33% (56.36%)
Return on assets (63.45%) (57.62%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANIX ATRA Biotechnology median
Revenue growth (TTM) (34.10%) (96.72%) 6.02%
EPS growth (last fiscal year) 12.82% 122.52% 30.26%
Revenue growth, 5-year CAGR (6.89%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX ATRA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.55 1.98 4.72
Net debt to EBITDA 1.29 (0.22) 0.96

Dividend

Metric ANIX ATRA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANIX ATRA Biotechnology median
Market cap 96.65m 96.86m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack